TRAnexamic Acid for Preventing postpartum hemorrhage following a Cesarean Delivery :a multicenter randomised, double blind placebo controlled trial (TRAAP2) - TRAAP2

CHU de Bordeaux0 个研究点目标入组 4,524 人开始时间: 2017年6月12日最近更新: 2020年6月8日

试验速览

暂无简介。

•adult women admitted for a cesarean delivery before or during labor, at a term = 34 weeks, hemoglobin level at the last blood sample >9g/dl, blood Formula numbering within 3 days before caesarean delivery, informed signed consent
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 4524
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•previous thrombotic event or preexisting pro-thrombotic disease, epilepsy, any known cardiovascular, renal, liver disorder, severe hemorrhagic disease, autoimmune disease, sickle cell disease, placenta praevia, placenta accreta/increta/percreta, abruption placentae, eclampsia, HELLP syndrome, in utero fetal death, administration of low-molecular-weight heparin or antiplatelet agents during the week before delivery, general anesthesia, instrumental extraction failure, multiple pregnancy with genital delivery of the first twin and caesarean delivery for the second or at third trimester

发起方

CHU de Bordeaux